造影剤注入装置の世界市場予測（～2021年）：CT用造影剤注入器、MRI用造影剤注入器...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15

2 RESEARCH METHODOLOGY 16
2.1 RESEARCH METHODOLOGY STEPS 16
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 17
2.1.1.1 Secondary research 17
2.1.1.1.1 Key data from secondary sources 17
2.1.1.2 Primary research 18
2.1.1.2.1 Key Insights from primary sources 20
2.1.1.3 Key industry insights 21
2.1.2 MARKET SIZE ESTIMATION METHODOLOGY 21
2.1.3 RESEARCH DESIGN 23
2.1.4 MARKET DATA VALIDATION AND TRIANGULATION 24
2.1.5 ASSUMPTIONS 25

3 EXECUTIVE SUMMARY 26
3.1 INTRODUCTION 26
3.2 CONCLUSION 28

4 PREMIUM INSIGHTS 29
4.1 CONTRAST MEDIA INJECTORS: MARKET OVERVIEW 29
4.2 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION AND BY PRODUCT 30
4.3 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION AND BY REGION 31
4.4 GEOGRAPHIC SNAPSHOT: CONTRAST MEDIA INJECTORS MARKET 31

5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Large number of approvals for contrast agents 33
5.2.1.2 Increasing number of public and private diagnostic centers 33
5.2.2 RESTRAINTS 34
5.2.2.1 Risks associated with contrast media injectors 34
5.2.2.2 High cost of contrast media injectors and consumables & accessories 34
5.2.2.3 Reluctance to adopt new technology 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Technological advancements in contrast media injectors arena 35
5.2.3.1.1 IT-enabled solutions for contrast media injectors 35
5.2.3.1.2 Syringeless and dual-head injectors 35
5.2.3.2 Increasing focus of market players on contrast media injector arena 36
5.2.4 CHALLENGES 36
5.2.4.1 Development of gamma and neutron imaging solutions 36
5.2.4.2 Shortage of and need for highly skilled professionals 37
5.2.4.3 Development of biomarkers 37

6 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT 38
6.1 INTRODUCTION 39
6.2 INJECTOR SYSTEMS 40
6.2.1 CT INJECTOR SYSTEMS 42
6.2.2 MRI INJECTOR SYSTEMS 43
6.2.3 ANGIOGRAPHY INJECTOR SYSTEMS 43
6.3 CONSUMABLES 44
6.3.1 INJECTOR HEADS 45
6.3.1.1 Single head injectors 46
6.3.1.2 Dual head injectors 47
6.3.1.3 Syringeless injectors 47
6.3.2 SYRINGES 48
6.3.3 TUBING 49
6.3.4 OTHER CONSUMABLES 49
6.4 ACCESSORIES 50

7 GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION 51
7.1 INTRODUCTION 52
7.2 RADIOLOGY 53
7.3 INTERVENTIONAL CARDIOLOGY 54
7.4 INTERVENTIONAL RADIOLOGY 55

8 CONTRAST MEDIA INJECTORS MARKET, BY REGION 57
8.1 INTRODUCTION 58
8.2 NORTH AMERICA 60
 
8.2.1 U.S. 63
8.2.1.1 Increasing number of diagnostic imaging tests and centers 63
8.2.1.2 Rising prevalence of chronic diseases and increasing aging population 63
8.2.1.3 Prevalence of Alzheimer’s disease and other dementias 64
8.2.2 CANADA 67
8.2.2.1 Rising aging population, high incidence of cancer, CVD, and diabetes 67
8.2.2.2 MRI and CT examinations likely to boost the market 67
8.2.2.3 Increasing number of cardiac arrest cases 68
8.3 EUROPE 70
8.3.1 EUROPE 3 74
8.3.1.1 Germany: increasing number of diagnostic imaging procedures 74
8.3.1.2 France: increasing incidences and prevalence of cancer 75
8.3.1.3 U.K.: lack of sufficient instruments 75
8.3.2 ROE 77
8.3.2.1 Increased focus of market players on RoE countries 78
8.3.2.2 Russia: Initiatives by government to improve healthcare 78
8.4 ASIA-PACIFIC 81
8.4.1 RISE IN AGING POPULATION AND CANCER INCIDENCE 82
8.4.2 EXPANSION OF INTERNATIONAL PLAYERS IN CHINA AND INDIA 82
8.4.3 FAVORABLE REGULATORY CHANGES IN NEW ZEALAND AND AUSTRALIA 83
8.4.4 HEALTHCARE REFORMS, GOVERNMENT INITIATIVES, AND INVESTMENTS IN CHINA 83
8.5 REST OF THE WORLD 86
8.5.1 LATIN AMERICA 87
8.5.2 THE MIDDLE EAST 88
8.5.3 AFRICA 88

9 COMPETITIVE LANDSCAPE 92
9.1 OVERVIEW 92
9.2 MARKET SHARE ANALYSIS 92
9.2.1 BRACCO IMAGING S.P.A 92
9.2.2 BAYER HEALTHCARE 93
9.2.3 GUERBET GROUP 93
9.3 COMPETITIVE SCENARIO 95
9.3.1 OTHER STRATEGIES 95
9.3.2 PRODUCT DEPLOYMENT 96
9.3.3 PRODUCT LAUNCH 96
9.3.4 MARKET DEVELOPMENTS (PRODUCT APPROVALS) 97
 

10 COMPANY PROFILES 98
(Overview, Financial*, Products & Services, Strategy, and Developments)
10.1 BAYER AG (MEDRAD INC.) 99
10.2 BRACCO IMAGING S.P.A. 102
10.3 GUERBET GROUP 104
10.4 ULRICH GMBH & CO. KG. 107
10.5 NEMOTO KYORINDO CO., LTD 109
10.6 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD. (SINOMDT) 110
10.7 APOLLO RT CO., LTD. 111
10.8 VIVID IMAGING 112
10.9 ANGIODYNAMICS (NAVILYST MEDICAL, INC) 113
10.10 GE HEALTHCARE 115
*Details might not be captured in case of unlisted companies.

11 APPENDIX 117
11.1 DISCUSSION GUIDE 117
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 121
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 123
11.4 AVAILABLE CUSTOMIZATIONS 124
11.5 RELATED REPORTS 124
11.6 AUTHOR DETAILS 125